文档详情

论文-血清胱抑素C检测对肝硬化患者肾功能损害的诊断价值.doc

发布:2017-04-21约8.7千字共8页下载文档
文本预览下载声明
东南大学检验本科毕业论文·血清胱抑素C对检测肝硬化患者肾功能损害的诊断价值 毕业设计报告(论文) 课题名称 血清胱抑素C检测对肝硬化 患者肾功能损害的诊断价值 专 业 学 号 学生姓名 指导教师 起讫日期 工作地点 第  PAGE \* MERGEFORMAT 7 页 共6页 血清胱抑素C检测对肝硬化患者肾功能损害的诊断价值 摘要 目的 通过检测肝硬化患者血清胱抑素C(Cys C)的水平,探讨血清Cys C在肝硬化患者早期肾功能损害中的诊断价值及意义。方法 采用免疫比浊法检测118例肝硬化、48例CHB患者及30例健康对照组血清Cys C、β2微球蛋白(β2-MG)水平,同时采用酶法测定血清肌酐(Scr)、尿素(Urea)水平。对各组血清Cys C、Scr、Urea及β2-MG水平差异、相关性及异常率进行比较分析。结果 肝硬化组、CHB组和对照组的血清Cys C水平分别为(1.29±0.33)mg/L、(0.98±0.21)mg/L和(0.92±0.15)mg/L,肝硬化组显著高于CHB组(P<0.001)和对照组(P<0.001)。肝硬化组Scr、Urea和β2-MG水平分别为(69.22±21.21)μmol/L、(5.47±2.16)mmol/L和(2.58±0.88)mg/L,均显著高于对照组(P均<0.001)。各组血清Cys C与Scr均呈正相关,肝硬化组(r=0.502,P<0.001),CHB组(r=0.485,P<0.001),对照组(r=0.494, P<0.01)。肝硬化组血清Cys C异常率(75.4%)显著高于Scr(5.9%)、Urea(17.8)% 和β2-MG(22%),(P均<0.001)。结论 血清Cys C可以作为评价肝硬化早期肾功能损害的标志物,为临床相关疾病的诊断提供参考依据。 关键词:胱抑素C; 肌酐; 尿素; β2微球蛋白; 肝硬化 abstract Objective To explore the diagnostic value and significance of Cystatin C (Cys C)serum level in the evaluation of renal funtion in patients with liver cirrhosis. Methods Serum Cys C and β2 microglobulin (β2-MG) levels were detected by immunoturbidimetric assay in 118 patients with liver cirrhosis, 48 patients with Chronic hepatitis B(CHB) and 30 healthy group as Control,while Serum creatinine (Scr) and Urea were measured using enzymatic method.Furthermore, The differences of serum Cys C, Scr, Urea, β2-MG levels and their relationships between groups were analyzed. Results The serum Cys C levels were (1.29±0.33)mg/L(Liver cirrhosis group), (0.98±0.21)mg/L (CHB group) and (0.92±0.15)mg/L(Control group) respectively,Liver cirrhosis group was significantly higher than CHB group (P0.001) and Control group (P 0.001). The Scr, Urea and β2-MG levels in liver cirrhosis group were (69.22 ± 21.21) μmol/L, (5.47±2.16) mmol/L and (2.58±0.88)mg/L respectively, a
显示全部
相似文档